Global Cannabis Market Report (2022 to 2027) – Emergence of Cannabis Legalization in Asia-Pacific Presents Opportunities – GlobeNewswire

Dublin, Oct. 07, 2022 (GLOBE NEWSWIRE) — The „Global Cannabis Market by Product Type (Flowers, Concentrates, Edibles, Topicals & Tinctures), Compound (THC-Dominant, CBD-Dominant, Balanced THC & CBD), Application (Medical, Recreational), and Region (North America, South America, Europe, RoW) – Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.

The global cannabis market is estimated to be valued at USD 27.7 billion in 2022 and is projected to reach USD 82.3 billion by 2027, recording a CAGR of 24.3% in terms of value.

The market is driven by the rise in the use of cannabis for recreational and medical use. Moreover, there has been an increased legalization of cannabis in the US in states like Virginia in 2021 and Rhode Island in 2022 and in other countries like in Malta in 2021, and Thailand in 2018.

The cannabis industry is growing rapidly and witnessing a double-digit growth rate globally. There are several major companies operating in the cannabis segment that dominate their respective markets. Thus, companies are competing to gain a significant market share.

By application, the recreational segment is projected to grow at the highest CAGR during the forecast period

Recreational cannabis demand is increasing continuously driven by Gen Z consumers. A small but encouraging portion of cannabis products are being sold to women due to a shift in public opinion, and this percentage is predicted to increase over time. Moreover, legalization has have led to a trend toward cannabis-related tourism, with locations producing novel holiday items to entice clients and increasing travel bookings to cannabis-legal destinations.

By compound, the THC-dominant segment is estimated to account for the largest share

THC strain is used for both medical and recreational applications, which increases its demand among manufacturers as well as consumers. Growing Together Research Inc., an Indiana-based biotechnology business, has created a new technique for genetically regulating the expression of Delta-9-THC in cannabis, including the capacity to boost cannabinoid levels in marijuana varieties grown for recreational or medical purposes. Moreover, other forms of THC, such as delta-8-THC, are gaining popularity in addition to the conventional version.

The European region is projected to grow at the highest CAGR during the forecast period

The market in Europe is majorly driven by the awareness of medical benefits of cannabis in the region coupled with the healthcare system present in several European countries that covers the health expenditure of most patients in these regions.

As the legalization of cannabis in European countries is at a nascent stage, this creates a considerable opportunity for companies to establish themselves in the region. Since the beginning of 2019, the European cannabis market has witnessed multiple mergers and acquisitions involving companies focused on medical cannabis. Like in the starting of 2021 medical cannabis firm GW Pharmaceutical was acquired by Jazz Pharmaceutical for USD 6.15 Billion.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Attractive Opportunities in Cannabis Market
4.2 Cannabis Market: Major Regional Submarkets
4.3 North America: Cannabis Market, by Compound and Country
4.4 Cannabis Market, by Application
4.5 Cannabis Market, by Compound
4.6 Cannabis Market, by Product Type and Region

5 Market Overview
5.1 Introduction
5.2 Macroeconomic Indicators
5.2.1 Increase in Aging Population
5.2.2 Economic Downturn
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Cannabis Demand for Medicinal Applications
5.3.1.2 Legalization of Cannabis and Rise in Social Acceptance
5.3.1.3 Growth in R&D Activities and Technological Advancements to be Precursors for Cannabis Business
5.3.1.4 Rising Global Cannabis Sales Helping Online Retailers Expand
5.3.2 Restraints
5.3.2.1 Complex Regulatory Structure for Use of Cannabis
5.3.2.2 Problems Associated with High Dose of Cannabis Consumption
5.3.2.3 Stigmatization of Cannabis Market
5.3.2.4 Profit Margins of Manufacturers Shrinks as Cannabis Prices Fall
5.3.3 Opportunities
5.3.3.1 Emergence of Cannabis Legalization in Asia-Pacific
5.3.3.2 Edibles, Led by Gummies and Chocolates, to Present Additional Growth Opportunities for Cannabis Business
5.3.3.3 Inorganic Growth Strategies Adopted by US Cannabis Companies
5.3.4 Challenges
5.3.4.1 Intensive Water Consumption and Inability to Maintain Consistency During Cannabis Cultivation
5.3.4.2 Cannabis-Producing Businesses Face Financing Difficulties in US
5.3.4.3 Advertising and Marketing Restrictions in US
5.3.4.4 Supply Chain Challenges Associated with Cannabis in US

6 Industry Trends
6.1 Introduction
6.2 Value Chain
6.2.1 Research and Product Development
6.2.2 Raw Material Sourcing
6.2.3 Production
6.2.4 Packaging, Storage, and Distribution
6.2.5 Retail
6.3 Supply Chain Analysis
6.4 Trends/Disruptions Impacting Customers’ Businesses
6.4.1 Revenue Shift and New Revenue Pockets in Cannabis Market
6.5 Market Mapping and Ecosystem of Cannabis Market
6.5.1 Demand-Side
6.5.2 Supply-Side
6.5.3 Ecosystem Map
6.6 Technology Analysis
6.6.1 Led Glow Light
6.6.2 Nanoencapsulation
6.6.3 Artificial Intelligence and Blockchain
6.6.4 Crop Steering
6.6.5 Vertical Farming
6.6.6 Innovative Hardware Tech Devices
6.6.7 IoT Automation
6.6.8 Genetic Engineering
6.7 Pricing Analysis
6.7.1 Selling Prices Charged by Key Players in Terms of Product Type
6.8 Cannabis Market: Patent Analysis
6.8.1 List of Major Patents
6.9 Trade Analysis: Cannabis Market
6.9.1 Export Scenario of Hemp
6.9.2 Import Scenario of Hemp
6.10 Case Studies: Cannabis Market
6.10.1 Filter420: Attempts to Build Brand Value
6.10.2 Onyx Agronomics: Precision Cannabis Facility
6.11 Key Conferences and Events, 2022-2023
6.12 Tariff and Regulatory Landscape
6.13 Porter’s Five Forces Analysis
6.14 Key Stakeholders and Buying Criteria

7 Cannabis Market, by Product Type
7.1 Introduction
7.2 Flowers
7.2.1 Automation and Sustainable Packaging to be Key Trends in Pre-Roll Domain
7.3 Concentrates
7.3.1 Various Delivery Methods Resulted in Consumer-Friendly Cannabis Concentrates Market
7.4 Edibles
7.4.1 Food and Beverage Manufacturing Companies Venture into Cannabis-Infused Edibles
7.5 Topicals & Tinctures
7.5.1 Topicals Witness Increased Demand in Skincare Industry
7.6 Other Product Types

8 Cannabis Market, by Compound
8.1 Introduction
8.2 Tetrahydrocannabinol (THC)-Dominant
8.2.1 Increasing Legalization of Recreational Cannabis Propels THC-Dominant Cannabis Market
8.3 Cannabidiol (CBD)-Dominant
8.3.1 Increased Popularity of CBD Edibles to Drive CBD-Dominant Cannabis Products Market
8.4 Balanced THC & CBD
8.4.1 Balanced THC & CBD Strains Witness Growth as CBD Diminishes Psychoactive Properties of THC

9 Cannabis Market, by Application
9.1 Introduction
9.2 Medical
9.2.1 Increase in Cannabis Use for Treatment of Various Ailments Drives Demand for Medical Cannabis
9.2.1.1 Pain Management
9.2.1.2 Neurological Health Management
9.2.1.3 Mental Health Management
9.2.1.4 Other Medical Applications
9.3 Recreational
9.3.1 Wider Legalization Status of Recreational Cannabis to Boost Market Growth

10 Cannabis Market, by Region

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, 2021
11.3 Segmental Revenue Analysis of Key Players
11.4 Key Player Strategies
11.5 Company Evaluation Quadrant (Key Players)
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.5.5 Product Footprint
11.6 Cannabis Market: Evaluation Quadrant for Startups/SMEs, 2021
11.6.1 Progressive Companies
11.6.2 Starting Blocks
11.6.3 Responsive Companies
11.6.4 Dynamic Companies
11.6.5 Competitive Benchmarking of Key Startups/SMEs
11.7 Product Launches, Deals, and Other Developments
11.7.1 Product Launches
11.7.2 Deals
11.7.3 Others

12 Company Profiles
12.1 Introduction
12.2 Key Players
12.2.1 Canopy Growth Corporation
12.2.2 Curaleaf
12.2.3 Cresco Labs
12.2.4 Green Thumb Industries
12.2.5 Tilray
12.2.6 Trulieve
12.2.7 Aurora Cannabis Inc.
12.2.8 Medmen
12.2.9 Unrivaled Brand Inc.
12.2.10 Organigram Holdings Inc.
12.2.11 Stenocare
12.2.12 Vivo Cannabis Inc.
12.2.13 Terrascend
12.2.14 Hexo Corp
12.2.15 Village Farms International Inc.
12.2.16 Verano
12.3 Other Players (SMEs/Startups)
12.3.1 The Cronos Group
12.3.2 Medical Marijuana, Inc.
12.3.3 Ecofibre Limited
12.3.4 Indiva
12.3.5 Tikun Olam-Cannbit Pharmaceuticals Ltd.
12.3.6 Maricann Group Inc.
12.3.7 Satipharm
12.3.8 Cannabliss Organic LLC
12.3.9 Connected Cannabis Co.
12.3.10 Justice Cannabis Co.
12.3.11 Henry’s Original

13 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/8z0dog

Attachment


Global Cannabis Market Report (2022 to 2027) – Emergence of Cannabis Legalization in Asia-Pacific Presents Opportunities – Yahoo Finance


Company Logo

Company Logo

Global Cannabis Market

Global Cannabis Market

Global Cannabis Market

Dublin, Oct. 07, 2022 (GLOBE NEWSWIRE) — The „Global Cannabis Market by Product Type (Flowers, Concentrates, Edibles, Topicals & Tinctures), Compound (THC-Dominant, CBD-Dominant, Balanced THC & CBD), Application (Medical, Recreational), and Region (North America, South America, Europe, RoW) – Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.

The global cannabis market is estimated to be valued at USD 27.7 billion in 2022 and is projected to reach USD 82.3 billion by 2027, recording a CAGR of 24.3% in terms of value.

The market is driven by the rise in the use of cannabis for recreational and medical use. Moreover, there has been an increased legalization of cannabis in the US in states like Virginia in 2021 and Rhode Island in 2022 and in other countries like in Malta in 2021, and Thailand in 2018.

The cannabis industry is growing rapidly and witnessing a double-digit growth rate globally. There are several major companies operating in the cannabis segment that dominate their respective markets. Thus, companies are competing to gain a significant market share.

By application, the recreational segment is projected to grow at the highest CAGR during the forecast period

Recreational cannabis demand is increasing continuously driven by Gen Z consumers. A small but encouraging portion of cannabis products are being sold to women due to a shift in public opinion, and this percentage is predicted to increase over time. Moreover, legalization has have led to a trend toward cannabis-related tourism, with locations producing novel holiday items to entice clients and increasing travel bookings to cannabis-legal destinations.

By compound, the THC-dominant segment is estimated to account for the largest share

THC strain is used for both medical and recreational applications, which increases its demand among manufacturers as well as consumers. Growing Together Research Inc., an Indiana-based biotechnology business, has created a new technique for genetically regulating the expression of Delta-9-THC in cannabis, including the capacity to boost cannabinoid levels in marijuana varieties grown for recreational or medical purposes. Moreover, other forms of THC, such as delta-8-THC, are gaining popularity in addition to the conventional version.

The European region is projected to grow at the highest CAGR during the forecast period

The market in Europe is majorly driven by the awareness of medical benefits of cannabis in the region coupled with the healthcare system present in several European countries that covers the health expenditure of most patients in these regions.

As the legalization of cannabis in European countries is at a nascent stage, this creates a considerable opportunity for companies to establish themselves in the region. Since the beginning of 2019, the European cannabis market has witnessed multiple mergers and acquisitions involving companies focused on medical cannabis. Like in the starting of 2021 medical cannabis firm GW Pharmaceutical was acquired by Jazz Pharmaceutical for USD 6.15 Billion.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Attractive Opportunities in Cannabis Market
4.2 Cannabis Market: Major Regional Submarkets
4.3 North America: Cannabis Market, by Compound and Country
4.4 Cannabis Market, by Application
4.5 Cannabis Market, by Compound
4.6 Cannabis Market, by Product Type and Region

5 Market Overview
5.1 Introduction
5.2 Macroeconomic Indicators
5.2.1 Increase in Aging Population
5.2.2 Economic Downturn
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Cannabis Demand for Medicinal Applications
5.3.1.2 Legalization of Cannabis and Rise in Social Acceptance
5.3.1.3 Growth in R&D Activities and Technological Advancements to be Precursors for Cannabis Business
5.3.1.4 Rising Global Cannabis Sales Helping Online Retailers Expand
5.3.2 Restraints
5.3.2.1 Complex Regulatory Structure for Use of Cannabis
5.3.2.2 Problems Associated with High Dose of Cannabis Consumption
5.3.2.3 Stigmatization of Cannabis Market
5.3.2.4 Profit Margins of Manufacturers Shrinks as Cannabis Prices Fall
5.3.3 Opportunities
5.3.3.1 Emergence of Cannabis Legalization in Asia-Pacific
5.3.3.2 Edibles, Led by Gummies and Chocolates, to Present Additional Growth Opportunities for Cannabis Business
5.3.3.3 Inorganic Growth Strategies Adopted by US Cannabis Companies
5.3.4 Challenges
5.3.4.1 Intensive Water Consumption and Inability to Maintain Consistency During Cannabis Cultivation
5.3.4.2 Cannabis-Producing Businesses Face Financing Difficulties in US
5.3.4.3 Advertising and Marketing Restrictions in US
5.3.4.4 Supply Chain Challenges Associated with Cannabis in US

6 Industry Trends
6.1 Introduction
6.2 Value Chain
6.2.1 Research and Product Development
6.2.2 Raw Material Sourcing
6.2.3 Production
6.2.4 Packaging, Storage, and Distribution
6.2.5 Retail
6.3 Supply Chain Analysis
6.4 Trends/Disruptions Impacting Customers’ Businesses
6.4.1 Revenue Shift and New Revenue Pockets in Cannabis Market
6.5 Market Mapping and Ecosystem of Cannabis Market
6.5.1 Demand-Side
6.5.2 Supply-Side
6.5.3 Ecosystem Map
6.6 Technology Analysis
6.6.1 Led Glow Light
6.6.2 Nanoencapsulation
6.6.3 Artificial Intelligence and Blockchain
6.6.4 Crop Steering
6.6.5 Vertical Farming
6.6.6 Innovative Hardware Tech Devices
6.6.7 IoT Automation
6.6.8 Genetic Engineering
6.7 Pricing Analysis
6.7.1 Selling Prices Charged by Key Players in Terms of Product Type
6.8 Cannabis Market: Patent Analysis
6.8.1 List of Major Patents
6.9 Trade Analysis: Cannabis Market
6.9.1 Export Scenario of Hemp
6.9.2 Import Scenario of Hemp
6.10 Case Studies: Cannabis Market
6.10.1 Filter420: Attempts to Build Brand Value
6.10.2 Onyx Agronomics: Precision Cannabis Facility
6.11 Key Conferences and Events, 2022-2023
6.12 Tariff and Regulatory Landscape
6.13 Porter’s Five Forces Analysis
6.14 Key Stakeholders and Buying Criteria

7 Cannabis Market, by Product Type
7.1 Introduction
7.2 Flowers
7.2.1 Automation and Sustainable Packaging to be Key Trends in Pre-Roll Domain
7.3 Concentrates
7.3.1 Various Delivery Methods Resulted in Consumer-Friendly Cannabis Concentrates Market
7.4 Edibles
7.4.1 Food and Beverage Manufacturing Companies Venture into Cannabis-Infused Edibles
7.5 Topicals & Tinctures
7.5.1 Topicals Witness Increased Demand in Skincare Industry
7.6 Other Product Types

8 Cannabis Market, by Compound
8.1 Introduction
8.2 Tetrahydrocannabinol (THC)-Dominant
8.2.1 Increasing Legalization of Recreational Cannabis Propels THC-Dominant Cannabis Market
8.3 Cannabidiol (CBD)-Dominant
8.3.1 Increased Popularity of CBD Edibles to Drive CBD-Dominant Cannabis Products Market
8.4 Balanced THC & CBD
8.4.1 Balanced THC & CBD Strains Witness Growth as CBD Diminishes Psychoactive Properties of THC

9 Cannabis Market, by Application
9.1 Introduction
9.2 Medical
9.2.1 Increase in Cannabis Use for Treatment of Various Ailments Drives Demand for Medical Cannabis
9.2.1.1 Pain Management
9.2.1.2 Neurological Health Management
9.2.1.3 Mental Health Management
9.2.1.4 Other Medical Applications
9.3 Recreational
9.3.1 Wider Legalization Status of Recreational Cannabis to Boost Market Growth

10 Cannabis Market, by Region

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, 2021
11.3 Segmental Revenue Analysis of Key Players
11.4 Key Player Strategies
11.5 Company Evaluation Quadrant (Key Players)
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.5.5 Product Footprint
11.6 Cannabis Market: Evaluation Quadrant for Startups/SMEs, 2021
11.6.1 Progressive Companies
11.6.2 Starting Blocks
11.6.3 Responsive Companies
11.6.4 Dynamic Companies
11.6.5 Competitive Benchmarking of Key Startups/SMEs
11.7 Product Launches, Deals, and Other Developments
11.7.1 Product Launches
11.7.2 Deals
11.7.3 Others

12 Company Profiles
12.1 Introduction
12.2 Key Players
12.2.1 Canopy Growth Corporation
12.2.2 Curaleaf
12.2.3 Cresco Labs
12.2.4 Green Thumb Industries
12.2.5 Tilray
12.2.6 Trulieve
12.2.7 Aurora Cannabis Inc.
12.2.8 Medmen
12.2.9 Unrivaled Brand Inc.
12.2.10 Organigram Holdings Inc.
12.2.11 Stenocare
12.2.12 Vivo Cannabis Inc.
12.2.13 Terrascend
12.2.14 Hexo Corp
12.2.15 Village Farms International Inc.
12.2.16 Verano
12.3 Other Players (SMEs/Startups)
12.3.1 The Cronos Group
12.3.2 Medical Marijuana, Inc.
12.3.3 Ecofibre Limited
12.3.4 Indiva
12.3.5 Tikun Olam-Cannbit Pharmaceuticals Ltd.
12.3.6 Maricann Group Inc.
12.3.7 Satipharm
12.3.8 Cannabliss Organic LLC
12.3.9 Connected Cannabis Co.
12.3.10 Justice Cannabis Co.
12.3.11 Henry’s Original

13 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/8z0dog

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Aurora Cannabis Repurchases $23 Million of Convertible Notes – New Cannabis Ventures

Aurora Cannabis Repurchases ~US$23 Million Principal Amount of Convertible Notes; Balance Sheet Among Strongest in Industry

Balance Sheet Remains in Net Cash Position, Further Strengthened with Accretive Debt Reduction

EDMONTON, AB, Oct. 7, 2022 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that it has repurchased an aggregate of approximately $31.3 million (US$23.0 million) principal amount of its convertible senior notes (“Notes”) at a total cost, including accrued interest, of $29.8 million (US$21.8 million) in cash.

The purpose of the transaction, which represents a repurchase of a portion of the Notes at a 5.45% discount to par value, was to reduce the Company’s debt and annual cash interest costs. Annual cash interest savings from the repurchases of Notes made from Q3 2022 onwards now total approximately $11.9 million (US$8.7 million).

Aurora’s balance sheet remains amongst the strongest in the industry, with approximately $380 million of cash and cash equivalents (including approximately $52 million of restricted cash) inclusive of the transaction announced today, and the Company reiterates its expectation of achieving a positive Adjusted EBITDA run rate by December 31, 2022.

This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering would be unlawful.

About Aurora

Aurora is a global leader in the cannabis industry, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult-use brand portfolio includes Aurora Drift, San Rafael ’71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. Aurora also has a controlling interest in Bevo Farms, North America’s leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on Twitter and LinkedIn. Aurora’s common shares trade on the NASDAQ and TSX under the symbol “ACB”.

Original press release

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.


Get Our Sunday Newsletter


Liberty CBD Gummies (Scam Update Report) – Read Shocking Ingredients, Benefits, Usage & How Its Works – Outlook India

Liberty CBD Gummies are a great way to start taking care of your physical, mental, and neurological health as a whole. It is one of the most effective CBD oil infused gummies on the market. The gummies are made with natural and herbal ingredients that help with pain and mental health problems.
 
Liberty CBD is a cannabinoid oral gummy that has been clinically tested and approved, and the medicinal benefits of CBD oil support it. It helps you naturally overcome chronic conditions thanks to the healing properties of the CBD oil that are included in it. The CBD oil that is contained within the gummies helps to offer therapeutic effects, and it also supports nourishing psychological, physiological, and physical well-being. In addition, it alleviates the chronic pain felt throughout the body and enables you to lead a healthier lifestyle.

Liberty CBD Gummies – Key Supplement Details

Brand

Liberty CBD Gummies

Quality of Ingredients

★★★★★

Official website

Click Here

Classification

CBD oil infused gummies

Item Form

Gummy

Unit Count

30  Count

Product Benefits

  • Relieves Anxiety & Stress
  • Reduces Pain & Chronic Aches
  • Promotes Healthy Sleep
  • Enhances Focus & Clarity

Quality standards

  • Cold-Pressed & Unrefined CBD Oil
  • Advanced C02 Extraction Technology
  • Includes Full Spectrum Cannabinoids
  • Superior Sublingual Delivery System

Usage instructions

Chew and swallow a gummy at least once per day.

Age Range

Adult

Restrictions

  • Follow the directions given by the company that makes it.
  • Do not overdose
  • No one under the age of 18 can take the supplement.
  • Not allowed when pregnant or breast-feeding

Purchasing packages include:

One bottle is $60.05+$9.95 shipping

Two bottles $53.37+free shipping

Three bottles $39.91+free shipping

Availability

Liberty CBD Gummies are only available through the official website.

Flavor

Unflavored

Customer support

Phone : +1 (888) 616-4130

Email: care@newcbdforhealth.com

What are Liberty CBD Gummy Bears? And Do they Work?
Liberty CBD Oil relieves your pain from the inside out by collaborating with your body. And it starts doing its job very quickly. It has been demonstrated beyond a reasonable doubt after more than 20,000 clinical studies. These are compounds that are found in Liberty CBD Gummies. These cannabinoids are the SAME compounds that regulate mood and pain in the brain and throughout the body. Cannabinoids in CBD will tune your whole endocannabinoid system, the network of receptors found all over your body, in a matter of days (including your brain, organs, and glands). As a result, you will experience no pain and will have the feeling that you are much younger. In addition, pain in the muscles, joints, and arthritis, as well as headaches and general body aches, are all relieved. 
Order This FULL SPECTRUM CBD From The Official Website by Clicking Here

The following are some of the active ingredients found in Liberty CBD Gummies:
CBD Oil

CBD, also known as cannabidiol oil, relieves various common health issues, including anxiety and neurological disorders. This contributes to maintaining a healthy endocannabinoid system, which in turn helps regulate sleep, appetite, pain, and the immune system. Other benefits include an anti-inflammatory effect as well as a calming effect on the nervous system. The ability to sleep better and feel less anxious are two of its potential benefits as an antidepressant.

Hemp plant
The omega-3 and omega-6 fatty acids found in the hemp plant are beneficial to heart health, can reduce cholesterol and blood pressure, and may reduce your risk of stroke and cardiovascular disease. In addition, those suffering from cough, asthma, arthritis, or bloating will find relief after using it.

Coconut oil 
Coconut oil: increasing HDL cholesterol and lowering HbA1c with diet and exercise. Its antioxidants can be used to treat stress, the common cold, and even depression. In addition, the anti-inflammatory properties of this plant extract make it a useful weapon against skin infections. CBD gummies include an ingredient shown to boost digestion.

Rosemary
As an antiviral, antifungal, antibacterial, and anti-inflammatory herb, rosemary may help strengthen your body’s ability to fight off disease and protect you from getting sick. Because it lowers your blood sugar and improves your memory and mood, it makes it easier for you to concentrate and improves the quality of your performance. In addition, it improves digestion and the heart’s health, enabling the body to function at its highest potential.

Flavorings
The fruit extracts used in these Liberty CBD Gummies are a rich source of nutrients, proteins, and vitamins. Exotic fruits like the kiwi, blueberries, strawberries, pineapple, raspberries, guava, and mango.

Why would anyone use Liberty CBD Gummy?
People mostly use Liberty CBD Gummies to calm down and relieve pain. However, CBD has been studied to see if it can help with depression and anxiety . This cannabinoid is so relaxing that it has also been studied for anxiety, which keeps people from sleeping.
The results of a survey called „Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes” were published in the Journal of Pain Research in 2021. In this survey, 59% of people who answered said they had tried CBD for pain. A 2020 study called „Antioxidative and Anti-Inflammatory Properties of Cannabidiol” is just one of many that have been done on this cannabinoid’s possible ability to help with inflammation.
Order This FULL SPECTRUM CBD From The Official Website by Clicking Here

Liberty CBD gummies vs. Hemp gummies
CBD research is just starting, but it looks promising for treating conditions like insomnia and anxiety. Some have also used Liberty CBD to help relieve nausea, chronic pain, and depression. However, since Hemp contains neither cannabidiol nor tetrahydrocannabinol, hemp gummies do not have the same psychoactive effects as CBD gummies. Still, the anti-inflammatory properties of hempseed oil suggest it may help treat skin conditions like acne and psoriasis. And it has a decent amount of nutrients. However, don’t count on it to alleviate stress or put you to sleep.

Here is a quick look at the differences:
Liberty CBD gummies

•    CBD is what makes them work, and they may also have THC.
•    They come from the flowers of hemp plants that are old enough.
•    Most companies use carbon dioxide to get CBD out of the plant.
•    They might help relieve pain and give you other benefits.
Hemp gummies:
•    They don’t have CBD or THC in them.
•    They are made from oil from hemp seeds.
•    Manufacturers use cold-press mechanical extraction.
•    These gummies don’t have the same possible benefits as CBD.
•    From the hemp plant, they may have important fatty acids, vitamins, and trace minerals.

Liberty CBD Gummies BRAND is legit?
If you’re wondering if Liberty CBD Gummies are legit, we called the company’s customer service to get the scoop. They told us that their products are tested for quality and potency by an independent lab , so you can be sure you’re getting a pure and potent product. They also said that their products are made from organic, non-GMO Hemp and are free of pesticides, herbicides, and other harmful chemicals. So, if you’re looking for a high-quality CBD gummy, Liberty CBD is a great option.

Liberty CBD Gummy Bears, what exactly are the ingredients that make them work?
Liberty CBD Gummy Bears’ primary ingredient is hemp extract. The extracts used here are gathered straight from the farms where they grow. These capsules may contain a variety of all-natural ingredients and vitamins and minerals, not just hemp extracts. They don’t contain any artificial ingredients, dyes, flavors, preservatives, or stimulants. Fillers and artificial ingredients are not used in making these CBD oil infused gummies.

Every CBD  gummy is made in a clean, sterile facility using cutting-edge methods like triple filtration technology. This product’s full spectrum cannabinoids may provide long-term mental and physical health benefits. Additionally, the product is manufactured using cold-pressed methods, which may eliminate the use of potentially harmful chemicals. This product’s safe and all-natural construction ensures that it can be used repeatedly over time. In addition, the manufacturer’s website claims that a prescription isn’t required to purchase the product.

What about the safety of Liberty CBD Gummies?
These CBD Gummies have been tested and proven to be effective by numerous reviews. Multiple clinical trials have shown that this gummy works. It’s 100% pure CBD, and it does wonders for a wide range of medical problems. Furthermore, these CBD Gummies are powerful, legal, and do not cause addiction. Thus far, there have been no reports of any negative side effects. Clinical trials verified the efficacy of this supplement in treating chronic pain and confirmed its purity.

The Benefits of Trying Liberty CBD Gummies.
Cannabinoids used in these CBD Gummies come from domestically cultivated cannabis. Hemp is grown in a sustainable manner and put through rigorous clinical testing before it can help those in need after an extensive medical evaluation, monitoring, and approval. It does its work on the brain to make it healthier and more effective at its job, and it does this by supplying the body with the nutrients it needs. As a result, the immune system, muscle health, and joint health all see improvements. Detoxification is aided by this process, eliminating toxins harmful to the body. In addition, you’ll experience better digestion, a more positive disposition, less stress and anxiety, and fewer aches and pains. The gummies are a convenient, hassle-free method of treating the body and ridding oneself of these conditions.

Special Precautions and Warnings
Pregnancy and breast-feeding: While pregnant or nursing, CBD use should be avoided because of possible adverse effects on the developing baby. Unfortunately, CBD products may contain ingredients that are unsafe for a developing baby. So keep away from it to be safe.
Parkinson’s disease: For some people with Parkinson’s disease, taking high doses of CBD may worsen their tremors and other motor symptoms, according to preliminary research.

Where to buy Liberty CBD Gummies?
You should only purchase Liberty CBD Gummies from the company’s official online store. If you buy your Liberty CBD Gummies from a different location or a different URL, you run the risk of being scammed or receiving out-of-date or not genuine ones.

Liberty CBD Gummies Price:
On their official website, Liberty CBD Gummies provides several special offers, including: 
•    Purchasing one bottle will cost you $60.05 $9.95 shipping.
•    If you buy two bottles, you will receive one bottle for free, and the price per bottle will be $53.37 free shipping.
•    Pay only $39.91 free shipping per bottle when you buy three bottles and receive two free bottles when you do so.
•    (Special Offer) Click Here to Purchase This FULL SPECTRUM CBD at the Lowest Price Immediately

Frequently Asked Questions
1. Does Liberty CBD Gummies Really Work?

Many people wonder about this. Before investing, be aware of this product line’s side effects and scams. However, their claims are scientific. The product includes warnings. Before buying, make sure you know what you’re getting into. Consult a doctor about the side effects before using this product.

2. Is Liberty CBD Gummies Legit or Not?
Examining the ratings and comments left by previous purchasers is the most reliable method for determining the authenticity of a dietary supplement. For example, 75% of customers purchasing CBD products online recommend Liberty CBD Gummies. It’s the real deal!

3. Is Liberty CBD Gummies FDA approved?
The FDA has not conducted any kind of review of the claims that are made on the official website (U.S. Food & Drug Administration). The purpose of Liberty CBD Gummies is not to diagnose, treat, or prevent any disease. The information that is provided on the official website or by this company is not intended to serve as a replacement for an in-person consultation with your physician, nor should it be construed as individual medical advice.

4. Should you be concerned about Liberty CBD Gummies side effects?
No. To the best of our knowledge, no adverse reactions have been reported concerning the use of Liberty CBD Gummies. In addition, the ingredients that go into Liberty CBD Gummies are all-natural, so you shouldn’t have any cause for concern unless you have an allergy to one of the ingredients.

5. Why are there Liberty CBD Gummies bad reviews?
The product received excellent ratings from approximately 75% of customers who used it. So, not all negative reviews can be justified by the customers. Some of the reviews were written by impatient people who did not see any results from the product. However, some of the others are produced by competing businesses.

6. Is it safe to get Liberty CBD Gummies based on this review?
After putting a significant amount of time and effort into research, this article uncovered all relevant information. The purpose of this review is to present factual information. The purpose here is not to endorse anything; rather, it is to provide information. You are free to use your best judgment after reviewing the information presented here to decide whether or not to purchase Liberty CBD Gummies.

7. How to contact Liberty CBD Gummies company?
For customer service, Liberty CBD Gummies offers two ways to contact us: through Email at: care@newcbdforhealth.com or by Phone: +1 (888) 616-4130

Final Thoughts – Is Liberty CBD Gummies Right for You?
In conclusion, this product is worth considering for anyone looking to improve their health and overall well-being. These gummies are a simple way to add a variety of nutrients to your diet. Treatment of chronic pain is feasible without resorting to invasive measures like physical therapy or surgery. When it comes to fixing your health issues, these gummies made from natural ingredients are the best option. Using the product can help you relax and unwind. It’s helpful for people dealing with anxiety as well as those with physical problems. 
 


The same cannabinoids found in the brain and body that control mood and pain are found in Liberty CBD Gummies. In addition to relieving chronic pain, the same cannabinoid is used to treat epilepsy, anxiety, and insomnia. Using these gummies as directed, you will experience rapid relief from persistent pain. Antioxidants found in coconut oil are useful for treating stress, the common cold, and even depression. Rosemary’s antibacterial and antiviral properties may make it an ideal choice for those looking to boost their immune systems.
Order This FULL SPECTRUM CBD From The Official Website by Clicking Here

Disclaimer : The above is a sponsored post, the views expressed are those of the sponsor/author and do not represent the stand and views of Outlook editorial.
 

Bio Lyfe CBD Gummies : [Read Pros & Cons] Shocking Truth Exposed, Side Effects & Price to Buy – Outlook India

Are you looking for a pure and natural cannabidiol product? People now have a sensible alternative for treating various ailments using cannabidiol edibles. Over the past few years, a sharp rise in persons taking vitamins has been observed. CBD edibles are especially popular among Americans because of their wide range of flavors and hemp varieties. It takes a while to effect as they incorporate cannabidiol or CBD instead of tetrahydrocannabinol. 

(HUGE SAVINGS TODAY) Click Here to Buy Bio Lyfe CBD GummiesFor The Lowest Price Right Now

BioLyfe’s cannabidiol edibles, a brand-new CBD consumable, have been developed to give users in the United States and other areas a method for leading existences with less anxiety, adequate sleep, and far less severe pain. Another excellent approach to enjoying the therapeutic effects of cannabis without being concerned about spills or using the incorrect dosage is cannabidiol. So, let’s read more on Bio Lyfe CBD Gummies in this post below.

What exactly are Bio Lyfe’s supplements?

BioLyfe’s cannabidiol edibles are a brand-new cannabidiol chewable created from pure marijuana extraction. Every dosage contains ten milligrams of cannabidiol and is a fantastic option for people who have trouble ingesting capsules or tablets. These cannabidiol edibles from BioLyfe can also be carried in a backpack or a workout kit for training or outdoors.
No synthetic flavors, preservatives, or colors are present in BioLyfe’s cannabidiol edibles. They are under verification by outside companies that supply the components exactly as marketed to customers, ensuring that these cannabidiol gummies are created with the best possible ingredients.

These cannabidiol edibles from BioLyfe employ natural hemp extracts and are marketed as full-spectrum products. The candies are available in lemon, watermelon, lemonade, and cherry lime to ensure the consumer enjoys the flavor. The Bio Lyfe CBD Gummies include cannabidiol, spirulina, beet for coloring, and pectin for thickening. Bio Lyfe’s cannabidiol firm also uses elderberry vitamins C, D3, and elderberry for additional health benefits. BioLyfe’s cannabidiol edibles also contain vegan super meals and helpful ingredients like melatonin and turmeric to cure any medical problem.

Benefits of using Biolyf’s cannabidiol edibles:

(HUGE SAVINGS TODAY) Click Here to Buy Bio Lyfe CBD GummiesFor The Lowest Price Right Now

•    Biolyf’s edibles fortify one’s defenses against sickness and raise immunity.
•    These gummies aid in reducing stress and encouraging sleeping.
•    Cannabidiol BioLyf’s edibles can be utilized to manage temperament by lowering anxiousness.
•    Consuming these Bio Lyfe CBD Gummies after a stressful day at work can help you relax and energize the remainder of the evening. 
•    After even a lengthy day at work, parents can take their children on an evening excursion.

The working mechanism of using Biolyf’s cannabidiol edibles:

When cannabidiol has a positive, lengthy influence depends critically on the body mass, frequency, metabolism, and dosage of use. The benefits of BioLyfe’s cannabidiol chews must start to take action after five to fifteen minutes of consumption, and they could last for about six to eight hours. 

The recommended frequency of consumption for these Bio Lyfe CBD Gummies is once or twice a day for overall physical well-being. BioLyfe’s cannabidiol edibles promote not only good health but are also available in four formulation forms, including the following: 

•    It assists in promoting a positive mood.
•    These gummies aid in promoting sound sleep.
•    Biolyf’s edibles assist in improving joint and muscle health, 
•    These edibles promote immune system enhancement.

Effects of using Biolyf’s cannabidiol edibles on body, mind, and age:

(SPECIAL PROMO) Click Here to Buy Bio Lyfe CBD Gummiesat a Discounted Price While Supplies Last

The function of the mind, inflammation, sleeping and eating are all regulated by the ECS or endocannabinoid system. In a nutshell, the ECS involves ensuring that your organism functions properly. The effects of Bio Lyfe CBD Gummies are as follows:

•    Body or Organism: It causes your system to respond in a way that promotes movement and lessens pain. Consistent usage is believed to enhance joint health, mobility, and flexibility.

•    Central nervous system or brain: These cannabidiol edibles encourage healthy emotional control, which promotes tranquility, calmness, and normal sleep habits. It improves overall health as well.

•    Age: Along with many other things, innate immune inflammation generates all kinds of bodily duress. However, when it relates to repairing injured tissue, it is beneficial.

The need for BioLyfe’s cannabidiol edibles:

The developer and creator of these Bio Lyfe CBD Gummies recall the initial entrance into the industry for the wellness of individuals. They were concerned about the mood and energy levels of the individuals. When they employed cannabidiol in their lives, they could notice significant benefits from their initial and reasonably priced cannabidiol product.

The product has been produced after years of testing, creation, and study that allowed them to keep track of cannabidiol’s development in the medical sector and create a variety of high-quality cannabidiol products, including tinctures, balms, oils, gummies, etc. These gummies were created keeping those individuals in mind who experience many disorders, such as reduced strength, vitality, endurance, depression, anxiousness, and many more disorders.

Since the chews include organic neurotransmitters, these cannabidiol chews are well known for decreasing pain and anxiety. The candies also promote sound sleep, which enhances your body’s posture and balance.

The importance of cannabidiol:

Cannabinoids or CBD can be found in marijuana. The psychotropic component of marijuana, THC, the ingredient that gives marijuana its euphoric high, is absent from cannabidiol products, such as Bio Lyfe CBD Gummies. Even though cannabidiol oil is the most popular form of cannabidiol products, other options include extraction, vaporized solutions, and capsules. 

https://www.outlookindia.com/outlook-spotlight/biolife-keto-reviews-do-biolife-keto-pills-work-or-scam–news-220445

For instance, the FDA has endorsed the prescribed oil and cannabidiol medication Epidiolex. This product has gained FDA authorization that doesn’t occur very frequently for treating the signs and symptoms of two different types of epilepsy. The laws in each situation regarding cannabidiol consumption, however, are different. Cannabidiol is currently being researched more extensively as a therapeutic aid for many additional conditions, including schizophrenia and Parkinson’s. 

Pros of using Biolyf’s cannabidiol edibles:

•    Biolyf’s edibles assist in promoting immune response.
•    Bio Lyfe CBD Gummies have a relaxing effect, promote relaxation, and enhance sleeping patterns.
•    It gives you an added boost.

Cons of using Biolyf’s cannabidiol edibles:

•    New consumers of Biolyf’s edibles need to be informed that they may experience a few side effects as the organism becomes accustomed to the existence of exogenous cannabidiol.
•    Only Biolyf’s official portal sells these cannabidiol edibles.  
•    Any pregnant woman must not ingest cannabidiol edibles.
•    Anyone younger than 18 should avoid consuming these Bio Lyfe CBD Gummies.
•    BioLyf’s CBD edibles should always be in a safe, cool, and dry location.

Besides, naturally, cannabidiol carries several hazards, including appetite loss, dry mouth, tiredness, exhaustion, and diarrhea. This cannabis or hemp component also interacts with other medications, such as blood thinners. So, when you take prescribed medications, talk to your doctor before employing any cannabidiol product or supplements in your daily regimen.

Dosage of using Biolyf’s cannabidiol edibles

Two servings of Biolyf’s cannabidiol candies are required, one in the mornings and one in the evenings. When you consume the Bio Lyfe CBD Gummies, they enter your body, and you might not even be conscious of it. 

https://www.outlookindia.com/outlook-spotlight/liberty-cbd-gummies-shocking-side-effects-read-pros-cons–news-219684

Concerns about cannabidiol medicine dose and purity are also possible. In a new analysis, more than one-third of the cannabidiol products examined contained less cannabidiol than was stated on the packaging. THC was also detected in 18 of the items. To verify the composition, BioLyfe’s cannabidiol edibles’ makers send every lot to external third-party laboratories for testing.

Price of Biolyf’s cannabidiol edibles:

BioLyfe’s cannabidiol edibles are now only available through their official site. Prices or costs of these Bio Lyfe CBD Gummies range differently, including the following:

•    Two units (thirty gummies in each bottle) of Biolyf’s cannabidiol edibles come for 64.99 USD each and free delivery.
•    Three units (thirty gummies in each bottle) of Biolyf’s cannabidiol edibles come for 56.67 USD each and free delivery.
•    Five units (thirty gummies in each bottle) of Biolyf’s cannabidiol edibles come for 39.99 USD each and free delivery.

Customer support details for Biolyf’s cannabidiol edibles:

For inquiries or to reschedule delivery of Bio Lyfe CBD Gummies, call the customer service line at the number provided below:

•    Working hours- Monday to Sunday from 07:00 a.m. EST to 07:00 p.m. EST
•    Contact details- 914 580 9398

Conclusion:

Generally speaking, finding a firm that manufactures candies with organic cannabidiol is not challenging since we have discovered a genuine company and their product Biolyf’s cannabidiol edibles for your knowledge. The cannabidiol edibles made of synthetic cannabidiol won’t have any benefits and will adversely affect your overall health, mind, and mechanism. In contrast hand, natural cannabidiol edibles let one swiftly and successfully feel the true advantages of cannabis without aggravating already current health issues. 

These natural and pure cannabidiol edibles are introduced by Biolyf and significantly work on your mind and body. All goods from Biolyf, including their cannabidiol edibles, come with a 90-day cash back or refund warranty. Customer support may claim this warranty.

Consumers could be confident that every container of BioLyfe’s cannabidiol edibles has what is listed on the package: useful, chemical-free, vegan, and THC-free. So, do not delay or wait; buy Bio Lyfe CBD Gummies from its official site. When using it regularly, you will notice significant improvements in your body through process and general wellness.

Disclaimer : The above is a sponsored post, the views expressed are those of the sponsor/author and do not represent the stand and views of Outlook editorial.
 

European Cannabis Stocks Review: Akanda Becomes Second Cannabis Company To Face NASDAQ Delisting After Less Than A Year On The Market – BusinessCann

NEWS broke yesterday evening that US President Joe Biden has moved to federally pardon thousands of Americans with minor cannabis convictions. 

The news has sent North American cannabis stocks flying, with MSO’s across the US and Canada experiencing record gains, seeing Tilray, Curaleaf, Cresco Labs and Truelieve all shoot up over 30%. 

At the time of writing, the gains are yet to have had a major impact on European cannabis stocks, but movements are expected over the coming weeks. 

Despite the US finally making some progress on its promise of federal cannabis reform, some analysts remained skeptical. 

Capital Alpha Partners analyst Ian Katz wrote in a note Thursday that ‘if investors were betting that Biden’s action will lead to legalisation of marijuana, they will likely be disappointed.’

Akanda

As predicted by BusinessCann in July, Akanda has now joined its NASDAQ-listed stablemate IMC in being threatened with delisting from the exchange. 

Akanda, which listed its shares on NASDAQ just over six months ago, informed investors this week that it had received notification from the Listing Qualifications Department warning that it was ‘not in compliance with the minimum bid price requirement’. 

Under NASDAQ’s listing rules, securities are required to ‘maintain a minimum bid price of $1 per share’, and should share prices remain below this threshold for ‘30 consecutive days’, companies face being delisted. 

Following its listing in March 2022, Akanda’s share price skyrocketed to highs of around 350x its $4 listing price, but soon stabilised at around $8. 

The young cannabis company was able to maintain this strong valuation until early May, when its stock price fell off a cliff edge, dropping to just over $1. 

Since then, Akanda has struggled to keep its share price above this $1 threshold, but peaked above it three times between May and August, meaning the share price was never below $1 for 30 days straight. 

Since August, however, Akanda’s share price has entered a gradual decline, dropping from just over $1 to its current share price of around $0.4. 

According to its written notification from NASDAQ, Akanda has 180 calendar days, or until March 27, 2023, to bring its closing bid price above $1 for a minimum of 10 consecutive business days. 

“In the event the company does not regain compliance by March 27, 2023, the Company may be eligible for additional time to regain compliance or may face delisting.”

Meanwhile, IMC, which was handed the same warning on July 13, has until January 9, 2023 to bring its share price back above $1, a feat it has been unable to achieve since its notification. 

Voyager Life

CBD retailer Voyager Life, which joined the Aquis Stock Exchange just over a year ago, has seen its shares return to trading after a temporary suspension last week. 

Voyager is understood to have requested the temporary suspension following ‘press speculation’ that it was in line to rescue organic health product wholesaler Tree of Life UK from administration. 

According to an RNS, Voyager had been weighing up a potential acquisition of Tree of Life, which appointed Chris Pole and Ryan Grant as joint administrators on August 22, 2022.

Despite acknowledging that the ‘vertical integration with the company’s product range and our own brand manufacturing could create value’ for shareholders, Voyager ultimately decided to abandon its acquisition plans due to ‘several risk factors’. 

The speculation surrounding its acquisition is understood to have been driven by the recent consolidation of Cellular Goods and Cannaray Brands, a trend which Voyager’s ‘board of directors expect to continue’. 

As reported in Voyager’s full year results last month, the company has been exploring a number of consolidation and partnership opportunities, and has received a number of enquiries to date. 

“As the market in which it operates consolidates and further opportunities present themselves for Voyager to expand its range of activities, the Directors will continue to examine potential collaborations and combinations whilst at all times maintaining its conservative approach to running costs and the importance of sustainable revenue generation.”

Tilray Brands

The Canadian cannabis giant saw its stock edge up this week as it continued its push into the European medical cannabis market.

Tilray announced this week that it had successfully relaunched its EU GMP-produced medical cannabis oral solution in Ireland. 

Crucially, it has become one of a handful of cannabis medicines to be approved under Ireland’s Medical Cannabis Access Programme (MCAP), and receive approval for patient reimbursement.  

“The MCAP reimbursement approval is a tremendous step in providing patients with greater access to Tilray’s high-quality medical cannabis products that address their needs,” Tilray’s Chief Strategy Officer and Head of Business Denise Faltischek said. 

The company added that it ‘intends to supply Irish patients with its full suite of medical cannabis products when local regulations allow’. 

It follows news late last month that Tilray had received approval from the Italian Ministry of Health to import and distribute the same medical cannabis oral solution. 

Weeks earlier, reports suggested that Tilray had been in ‘talks’ with German Drug Commissioner Burkhard Blienert to ‘help develop responsible cannabis regulations’.

While the company continues to strengthen its position in the European cannabis market, like many cannabis stocks, its share price has remained largely dependent on developments across the Atlantic Ocean. 

One report published this week suggested that growing calls for a ‘Protecting Kids from Candy-Flavoured Drugs Act’ in the US Congress could further stymie the profit growth of US cannabis operators, as edibles are reportedly the most profitable form of retail cannabis. 

This weakening of gross profit margins for big cannabis companies means that, even if it is legalised at the federal level, ‘Congress may snatch defeat out of the jaws of victory, and ensure marijuana remains an unprofitable business for the foreseeable future,’ thus keeping share prices on their downward trajectories. 

Cannabis legalization measure faces opposition | News, Sports, Jobs – Minot Daily News

With fewer than six weeks left before this year’s midterm elections, a group has formed to oppose the passage of Measure 2, which would legalize recreational marijuana in North Dakota.

The committee Healthy and Productive North Dakota announced its entry in the debate over marijuana legalization in a news release, after paperwork was filed on Oct. 5, by Fargo addiction counselor Kristie Spooner. Spooner had served as the chair of a previous opposition effort that succeed in blocking a similar measure in 2018.

HPND is being supported in this effort by national organizations, including Luke Niforatos, the CEO of Protect Our Kids, and Connor Kubeisy, a policy associate from Smart Approaches to Marijuana serving as the campaign’s manager. In its press release, HPND said it would be working to educate North Dakotans about their concerns about recreational marijuana, with Niforatos saying, “The self-interested marijuana industry is hell bent on taking root in North Dakota, no matter the consequences for public health and public safety.”

HPND feels that Measure 2 would cause an increase in youth marijuana use and, ultimately, a rise in traffic accidents and marijuana-related emergency room visits.

“Measure 2 lacks critical safeguards that are needed to prevent youth from using marijuana,” Kubeisy said in the press release, claiming that Measure 2 doesn’t restrict how cannabis products will be advertised, lacks limitations on potency, as well as requirements for warning labels and child-resistant caps.

New Approach North Dakota, the committee sponsoring Measure 2, responded to some of the statements made in HPND’s release, with Mark Friese, NAND’s treasurer and a Fargo criminal law attorney, saying, “It’s disappointing to see Measure 2 opponents resorting to fear tactics right out of the gate rather than engaging in an intellectually honest debate.”

They shared a number of reports and studies, including one issued by the Colorado state government that found teen cannabis use has dropped in the 10 years since legalization was passed by voters in 2012.

According to the study, between 2013 and 2021 the percentage of Colorado high school students who consumed cannabis decreased from 19.7% to 13.3%. Another report issued by Washington state also indicated a significant drop over the last 10 years amongst 8th, 10th and 12th graders, decreasing 6.6%, 12.1%, and 10.8%, respectively. Additionally, a study published by the American Medical Association determined, “there were no significant associations between enactment of RMLs (recreational marijuana laws) or MMLs (medical marijuana laws) and marijuana use among high school students.”

“Studies conducted by public health departments in other states as well as peer-reviewed research consistently show that marijuana use among high schoolers does not increase following passage of adult-use legalization laws,” Friese concluded.

District 40 Rep. Matt Ruby, R-Minot, is a member of the Measure 2 sponsoring committee and also took issue with the notion that the measure disregarded public safety.

“I’m a father of four young children, and I’m behind Measure 2 precisely because it includes so many responsible safeguards and limitations. The language is based on a bill passed by a majority of my colleagues in the North Dakota House of Representatives, including many Republicans,” Ruby said, “To claim that Measure 2 was written without regard to public health and safety is simply not true.”

While the text of the measure doesn’t explicitly address some of the elements brought forward by HPND, Measure 2 does require that the state department created to regulate recreational marijuana would have until Oct. 1, 2023, to adopt necessary rules for this new industry. These rules would govern the transport, storage, advertising, packaging and labeling of recreational marijuana products, along with standards for testing and testing facilities.

“They are criticizing us for not including details in the measure, but the measure clearly contemplates all of the issues they raise. If we spelled out every last detail in the actual legislation, the bill would be extremely long and cumbersome for voters,” said NAND chairman David Owen.

Voters will have their say at the polls on Nov. 8.

Today’s breaking news and more in your inbox

Booker Statement on President Biden’s Executive Order on Cannabis – Senator Cory Booker

WASHINGTON, D.C. – U.S. Senator Cory Booker (D-N.J.) issued the following statement on President Biden’s Executive Order on cannabis:

“President Biden’s executive order is transformative for the lives of thousands of people and families harmed by our broken cannabis laws. This is a huge step forward toward a more just criminal justice system and more rational drug policy. 

“Now it’s time for Congress and states to put an end to our failed policies by legalizing and appropriately regulating cannabis, taxing cannabis, reinvesting proceeds in communities disproportionately harmed by the War on Drugs, and expunging criminal records for nonviolent drug offenses.”

In October 2021, Senator Booker urged the Department of Justice (DOJ) to use its existing authority under the Controlled Substances Act of 1970 (CSA) to begin the process of removing cannabis’s classification as a Schedule I drug. Decriminalizing cannabis at the federal level through this descheduling process will remedy the harm caused by decades of racial disparities in enforcement of cannabis laws and facilitate valuable medical research. In July 2022, Senator Booker again urged the Biden Administration to use its existing authority to remove cannabis and issue pardons to all individuals convicted of nonviolent cannabis-related offenses.

Sen. Booker’s letter to the DOJ can be found here.  

Sen. Booker’s letter to the Biden Administration can be found here